Platelet-rich plasma facial rejuvenation
Dermatology & Aesthetics
≈ ¥2000-4000
(≈ $280-560)
1 hr
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
Estimated cost for Platelet-rich plasma facial rejuvenation at general public hospitals in China is about ¥1400-3200, and at Grade 3A hospitals about ¥2000-4000, varying by hospital tier and region.
Main Uses
PRP autologous serum facial rejuvenation is primarily used for non-surgical cosmetic skin revitalization: stimulating collagen/elastin synthesis, improving skin texture/tone, reducing fine lines and acne scars, enhancing wound healing post-procedure (e.g., microneedling, laser resurfacing), and addressing mild-to-moderate photoaging. It is indicated for patients seeking minimally invasive, biocompatible alternatives to dermal fillers or botulinum toxin, particularly those with sensitive skin, contraindications to synthetic agents, or preference for autologous therapies.
Normal Range
PRP (Platelet-Rich Plasma) autologous serum facial rejuvenation is not a diagnostic blood test with quantitative laboratory reference ranges. It is a cosmetic procedural technique involving centrifugation of the patient’s own venous blood to isolate platelet-rich plasma (typically containing 3–5× baseline platelet concentration, i.e., ~1,000,000–1,500,000/μL vs. normal whole blood ~150,000–400,000/μL), followed by topical application or microinjection. No standardized 'normal range' exists for clinical efficacy parameters (e.g., growth factor levels, cytokine concentrations) due to lack of FDA/EMA-approved assays, inter-laboratory variability, and absence of validated biomarkers for treatment response.
Low Values - Possible Causes
Low platelet yield in PRP preparation may result from: 1) Thrombocytopenia (e.g., immune thrombocytopenic purpura, chemotherapy-induced myelosuppression); 2) Chronic platelet activation or consumption (e.g., DIC, sepsis, autoimmune disorders); 3) Anticoagulant use (e.g., aspirin, clopidogrel, warfarin) impairing platelet function and recovery; 4) Iron deficiency anemia or chronic inflammation reducing megakaryocyte production; 5) Advanced age or chronic kidney disease affecting platelet synthesis and turnover.
High Values - Possible Causes
Elevated platelet concentration in PRP may occur due to: 1) Reactive thrombocytosis (e.g., post-splenectomy, acute infection, iron deficiency, surgery recovery); 2) Primary myeloproliferative neoplasms (e.g., essential thrombocythemia); 3) Chronic inflammatory conditions (e.g., rheumatoid arthritis, IBD); 4) Malignancy-associated paraneoplastic thrombocytosis; 5) Inadequate centrifugation protocol (e.g., excessive g-force or duration causing leukocyte/erythrocyte contamination and falsely inflated platelet counts).